131 filings
Page 5 of 7
8-K
7yij klmrq8vca
9 Aug 17
Intra-Cellular Therapies Reports Second Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
4s1heq0jddb7
28 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
oumpub fp
10 May 17
Intra-Cellular Therapies Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
u40xt9i 9rkly
1 May 17
Intra-Cellular Therapies Provides Corporate Update On Schizophrenia Program
12:00am
8-K
7wg5zx
1 Mar 17
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2016 Financial Results and Provides Corporate Update
12:00am
8-K
7edj72p5ex 41
10 Jan 17
Entry into a Material Definitive Agreement
12:00am
8-K
exp8ib
9 Nov 16
Intra-Cellular Therapies Reports Third Quarter 2016 Financial Results and Provides Corporate Update
12:00am
8-K
tfb4dmhjrb30 tobi
28 Sep 16
Other Events
12:00am
8-K
088o1bhogpwfa1n2w7n
4 Aug 16
Results of Operations and Financial Condition
12:00am
8-K/A
h5v ouhtv5t
7 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
yj1wh319aaple17z 6p
30 Jun 16
Intra-Cellular Therapies Reports Completion of Enrollment of ITI-007-302 Phase 3 Clinical Trial for the Treatment of Schizophrenia
12:00am
8-K
296sfi qud855c
28 Jun 16
Other Events
12:00am
8-K
chlb8rwm7txfsm6vqm7
15 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7031hfhcbq3007
28 Apr 16
Results of Operations and Financial Condition
12:00am
8-K
w5gcgi
6 Apr 16
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
12:00am
8-K
gksjucl3whxiet5h9if
25 Feb 16
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2015 Financial Results and Provides Corporate Update
12:00am
8-K
kg8o1o1xq ew
10 Dec 15
Other Events
12:00am
8-K
9whwv0n54jrue4a4fy
5 Nov 15
Intra-Cellular Therapies Reports Third Quarter 2015 Financial Results and Provides Corporate Update
12:00am
8-K
i9oa0ybeb0
28 Sep 15
Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including
12:00am
8-K
hl8mruh5vzfwcxrbju
23 Sep 15
Entry into a Material Definitive Agreement
12:00am